197 related articles for article (PubMed ID: 23036648)
21. Cannabis clubs in Uruguay: The challenges of regulation.
Queirolo R; Boidi MF; Cruz JM
Int J Drug Policy; 2016 Aug; 34():41-8. PubMed ID: 27475713
[TBL] [Abstract][Full Text] [Related]
22. Individual dollar expenditure and earnings from cannabis in the New Zealand population.
Wilkins C; Sweetsur P
Int J Drug Policy; 2007 May; 18(3):187-93. PubMed ID: 17689365
[TBL] [Abstract][Full Text] [Related]
23. The long and winding road to cannabis legalization.
Van Ours JC
Addiction; 2012 May; 107(5):872-3. PubMed ID: 22471565
[No Abstract] [Full Text] [Related]
24. A review of the world cannabis situation.
Leggett T;
Bull Narc; 2006; 58(1-2):1-155. PubMed ID: 19066071
[TBL] [Abstract][Full Text] [Related]
25. Cannabis cultivation in Quebec: between space-time hotspots and coldspots.
Chadillon-Farinacci V; Apparicio P; Morselli C
Int J Drug Policy; 2015 Mar; 26(3):311-22. PubMed ID: 25620750
[TBL] [Abstract][Full Text] [Related]
26. [Medical grade cannabis (MGC): regulation mechanisms, the present situation around the world and in Israel].
Shelef A; Mashiah M; Schumacher I; Shine O; Baruch Y
Harefuah; 2011 Dec; 150(12):913-7, 935, 934. PubMed ID: 22352285
[TBL] [Abstract][Full Text] [Related]
27. Qualitative research in Spanish cannabis social clubs: "The moment you enter the door, you are minimising the risks".
Belackova V; Tomkova A; Zabransky T
Int J Drug Policy; 2016 Aug; 34():49-57. PubMed ID: 27461986
[TBL] [Abstract][Full Text] [Related]
28. The three betrayals of the medical cannabis growing activist: From multiple victimhood to reconstruction, redemption and activism.
Klein A; Potter GR
Int J Drug Policy; 2018 Mar; 53():65-72. PubMed ID: 29287224
[TBL] [Abstract][Full Text] [Related]
29. Global patterns in small-scale cannabis growers' distribution practices: Exploring the grower-distributor nexus.
Søgaard TF; Brummer JE; Wilkins C; Sznitman SR; Sevigny EL; Frank VA; Potter G; Hakkarainen P; Barratt MJ; Werse B; Grigg J; Fortin D; Bear D; Lenton S; Jauffret-Roustide M; Kirtadze I
Int J Drug Policy; 2024 Jun; ():104463. PubMed ID: 38834441
[TBL] [Abstract][Full Text] [Related]
30. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
Costa Storti C; De Grauwe P
Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
[TBL] [Abstract][Full Text] [Related]
31. Additional considerations.
Nadelmann E; Gutwillig S; Davies J
Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
[No Abstract] [Full Text] [Related]
32. An economic analysis of different cannabis decriminalization scenarios.
Ogrodnik M; Kopp P; Bongaerts X; Tecco JM
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S309-14. PubMed ID: 26417786
[TBL] [Abstract][Full Text] [Related]
33. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
Reinarman C
Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
[TBL] [Abstract][Full Text] [Related]
34. Cannabis consumption patterns among frequent consumers in Uruguay.
Boidi MF; Queirolo R; Cruz JM
Int J Drug Policy; 2016 Aug; 34():34-40. PubMed ID: 27397717
[TBL] [Abstract][Full Text] [Related]
35. Propagating the Haze? Community and professional perceptions of cannabis cultivation and the impacts of prohibition.
Beckett Wilson H; Taylor S; Barrett G; Jamieson J; Grindrod L
Int J Drug Policy; 2017 Oct; 48():72-80. PubMed ID: 28810157
[TBL] [Abstract][Full Text] [Related]
36. Factors determining yield and quality of illicit indoor cannabis (Cannabis spp.) production.
Vanhove W; Van Damme P; Meert N
Forensic Sci Int; 2011 Oct; 212(1-3):158-63. PubMed ID: 21737218
[TBL] [Abstract][Full Text] [Related]
37. The results of an experimental indoor hydroponic Cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis.
Knight G; Hansen S; Connor M; Poulsen H; McGovern C; Stacey J
Forensic Sci Int; 2010 Oct; 202(1-3):36-44. PubMed ID: 20462712
[TBL] [Abstract][Full Text] [Related]
38. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
Davenport S; Pardo B
Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
[TBL] [Abstract][Full Text] [Related]
39. Supply-side harm reduction strategies: Bolivia's experiment with social control.
Farthing L; Kohl B
Int J Drug Policy; 2012 Nov; 23(6):488-94. PubMed ID: 22818891
[TBL] [Abstract][Full Text] [Related]
40. Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries.
Lenton S; Frank VA; Barratt MJ; Potter GR; Decorte T
Drug Alcohol Depend; 2018 Nov; 192():250-256. PubMed ID: 30292153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
